ArticleFrontiers in oncology2025

Glutamate metabotropic receptor 4 in breast cancer: a potential and specific target for chimeric antigen receptor therapy.

Yien Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.